~~<i id='5222E82414'><strike id='5222E82414'><tt id='5222E82414'><pre id='5222E82414'></pre></tt></strike></i>~~

Home» leisure time» explore

explore

author：focus 2025-09-06 08:33:01 Page View：2665

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Diabetes management: Digital health tools fall short, study says
Next article： Dobbs anniversary: the lost opportunity of abortion as health care

Wikipedia

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

Woman gored by Bison at Yellowstone

2:32FileimageofYellowstoneNationalPark.STOCKPHOTO/GettyImagesAwomanvisitingYellowstoneNationalParkwa

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Involuntary treatment for addiction doesn't work

ApersonpointstoadiscardedneedleinalotintheSouthBronx,NewYork.SpencerPlatt/GettyImagesAstheoverdosecr